PDT Partners’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
PDT Partners's TNDM Position: Q2 2026 in Review
PDT Partners reduced its Tandem Diabetes Care (TNDM) stake by 81% in Q2 2026, selling an estimated $1.33M and leaving 17,844 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #453.
PDT Partners first reported a position in TNDM in Q1 2014 and has held it in 19 quarters since. The position peaked at $7.01M in Q4 2020. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- PDT Partners held 17,844 shares of Tandem Diabetes Care worth $269K as of Q2 2026.
- PDT Partners sold 75,961 Tandem Diabetes Care shares in Q2 2026, an estimated $1.33M.
- Tandem Diabetes Care made up 0.01% of PDT Partners's portfolio in Q2 2026, its #453 holding.
- PDT Partners first reported a position in Tandem Diabetes Care in Q1 2014 and has held it in 19 quarters since.
- PDT Partners's Tandem Diabetes Care position peaked at $7.01M in Q4 2020.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.